|
Sanofi-aventis Faces Shareholder Lawsuit Over Zimulti
An institutional investor has filed a class action suit against sanofi-aventis, claiming the company made false statements about its weight loss drug Zimulti.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives